RE-BVS – Piemonte Repository

Sfoglia per AUTORE
ARRIGO G
Collezione AOU Città della Salute di Torino

Items : 8

Arsenic trioxide neurotoxicity in acute promyelocytic leukemia patients: a single center experience. in Leukemia & lymphoma / Leuk Lymphoma. 2025 Mar;66(3):567-568. doi: 10.1080/10428194.2024.2427266. Epub 2024 Nov 8.

2025
AOU Città della Salute di Torino

Urbino I; Giai V; Freilone R; Cerrano M; Celona L; Cattel F; Catania F; Boscaro E; Audisio E; Scaldaferri M; Arrigo G; D'Ardia S; Frairia C;

Sorafenib in combination with intensive chemotherapy for relapsed or refractory FLT3-ITD positive acute myeloid leukemia: A two centers experience. in Leukemia research / Leuk Res. 2024 Jan;136:107421. doi: 10.1016/j.leukres.2023.107421. Epub 2023 Nov 18.

2024
AOU Città della Salute di Torino

Ferrero D; Dellacasa CM; Busca A; Giaccone L; Lanzarone G; Bruno B; Freilone R; Giai V; Frairia C; D'Ardia S; Catania FM; Boscaro E; Arrigo G; Olivi M; Apolito V; Urbino I; Secreto C; Audisio E; Cerrano M;

Validation of SIE/SIES/GITMO consensus criteria for unfitness to predict early mortality and survival in acute myeloid leukaemia patients treated with hypomethylating agents and venetoclax. in British journal of haematology / Br J Haematol. 2023 Nov;203(4):e98-e101. doi: 10.1111/bjh.19022. Epub 2023 Aug 2.

2023
AOU Città della Salute di Torino

D'Ardia S; Frairia C; Audisio E; Beggiato E; Lanzarone G; Freilone R; Bruno B; Gravetti A; Copia C; De Simone MC; Di Biase F; Secreto C; Giai V; Perrone S; Olivi M; Vasseur L; Apolito V; Arrigo G; Ferrero D; Cerrano M; Ferrara F;

Thrombosis in Acute Myeloid Leukemia: Pathogenesis, Risk Factors and Therapeutic Challenges. in Current treatment options in oncology / Curr Treat Options Oncol. 2023 Jun;24(6):693-710. doi: 10.1007/s11864-023-01089-w. Epub 2023 Apr 26.

2023
AOU Città della Salute di Torino

Olivi M; Di Biase F; Lanzarone G; Arrigo G; Martella F; Apolito V; Secreto C; Freilone R; Bruno B; Audisio E; Ferrero D; Beggiato E; Cerrano M;

Validation of National Early Warning Score and Quick Sequential (sepsis-related) Organ Failure Assessment in acute myeloid leukaemia patients treated with intensive chemotherapy. in European journal of haematology / Eur J Haematol. 2023 Jun;110(6):696-705. doi: 10.1111/ejh.13952. Epub 2023 Mar 24.

2023
ASL Torino 4
AOU Città della Salute di Torino

Urbino I; Audisio E; Priolo G; Freilone R; Giai V; Evangelista A; Dellacasa C; D'Ardìa S; Cerrano M; Arrigo G; Busca A; Messa E; Secreto C; Nicolino B; Frairia C;

Modern Risk Stratification of Acute Myeloid Leukemia in 2023: Integrating Established and Emerging Prognostic Factors. in Cancers / Cancers (Basel). 2023 Jul 6;15(13):3512. doi: 10.3390/cancers15133512.

2023
AOU Città della Salute di Torino

Boscaro E; Urbino I; Catania FM; Arrigo G; Secreto C; Olivi M; D'Ardia S; Frairia C; Giai V; Freilone R; Ferrero D; Audisio E; Cerrano M;

Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature. in Acta haematologica / Acta Haematol. 2022;145(5):566-570. doi: 10.1159/000524878. Epub 2022 May 17.

2022
AOU Città della Salute di Torino

Arrigo G; D'Ardìa S; Audisio E; Cerrano M; Freilone R; Giai V; Secreto C; Urbino I; Frairia C;

Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study. in Leukemia / Leukemia. 2021 Jan;35(1):235-238. doi: 10.1038/s41375-020-0833-x. Epub 2020 Apr 14.

2021
AOU Città della Salute di Torino
AOU Novara

Gattei V; Cuneo A; Foà R; Polliack A; Gaidano G; Di Raimondo F; Bomben R; Rossi D; Rigolin GM; Del Giudice I; Biagi A; Arrigo G; Rago A; Angeletti I; Botta C; Tripepi G; Vigna E; Fraticelli V; Rossi FM; Zucchetto A; Scortechini I; Consoli U; Pietrasanta D; Loseto G; Moia R; Chiarenza A; Condoluci A; Murru R; Varettoni M; et alii...